US health panel urges restarting J&J Covid-19 vaccinations

The government will rapidly weigh that recommendation in deciding next steps

Doses of the J&J vaccines. Picture: Janssen Pharmaceutical Companies

A US health panel says it is time to resume use of Johnson & Johnson’s Covid-19 vaccine, despite a very rare risk of blood clots.

Out of nearly eight million people vaccinated before the US suspended using J&J’s shot, health officials uncovered 15 cases of a highly unusual kind of blood clot, three of them fatal. All were women, most younger than 50.